Dishman Carbogen Amcis Limited (DCAL.NS)

INR 193.06

(-0.01%)

Total Debt Summary of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited's latest annual total debt in 2023 was 23.12 Billion INR , up 4.7% from previous year.
Dishman Carbogen Amcis Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
Dishman Carbogen Amcis Limited reported annual total debt of 22.08 Billion INR in 2022, up 20.71% from previous year.
Dishman Carbogen Amcis Limited reported annual total debt of 18.29 Billion INR in 2021, up 15.17% from previous year.
Dishman Carbogen Amcis Limited reported quarterly total debt of 23.12 Billion INR for 2023 FY, up 4.7% from previous quarter.
Dishman Carbogen Amcis Limited reported quarterly total debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Debt Chart of Dishman Carbogen Amcis Limited (2023 - 2005)

Historical Annual Total Debt of Dishman Carbogen Amcis Limited (2023 - 2005)

Year	Total Debt	Total Debt Growth
2023	23.12 Billion INR	4.7%
2022	22.08 Billion INR	20.71%
2021	18.29 Billion INR	15.17%
2020	15.88 Billion INR	17.05%
2019	13.57 Billion INR	30.25%
2018	10.42 Billion INR	-4.81%
2017	10.94 Billion INR	15.28%
2016	9.49 Billion INR	0.73%
2015	9.42 Billion INR	1.08%
2014	9.32 Billion INR	5.97%
2013	8.8 Billion INR	-1.01%
2012	8.89 Billion INR	19.24%
2011	7.45 Billion INR	-14.19%
2010	8.68 Billion INR	12.4%
2009	7.73 Billion INR	7.01%
2008	7.22 Billion INR	9.79%
2007	6.57 Billion INR	17.3%
2006	5.6 Billion INR	72.34%
2005	3.25 Billion INR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	- INR	-100.0%
2023 FY	23.12 Billion INR	4.7%
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q4	23.12 Billion INR	0.0%
2023 Q2	23.07 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	22.08 Billion INR	0.0%
2022 FY	22.08 Billion INR	20.71%
2022 Q1	- INR	-100.0%
2022 Q2	20.38 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q4	18.29 Billion INR	0.0%
2021 Q2	15.51 Billion INR	0.0%
2021 FY	18.29 Billion INR	15.17%
2020 Q4	15.88 Billion INR	0.0%
2020 Q2	12 Billion INR	0.0%
2020 FY	15.88 Billion INR	17.05%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2019 FY	13.57 Billion INR	30.25%
2019 Q4	13.57 Billion INR	0.0%
2019 Q2	11.37 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2019 Q3	- INR	-100.0%
2018 Q4	10.42 Billion INR	0.0%
2018 FY	10.42 Billion INR	-4.81%
2018 Q3	- INR	-100.0%
2018 Q2	11.36 Billion INR	0.0%
2018 Q1	- INR	-100.0%
2017 FY	10.94 Billion INR	15.28%
2017 Q1	- INR	-100.0%
2017 Q2	9.51 Billion INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	10.94 Billion INR	0.0%
2016 Q2	7.71 Billion INR	0.0%
2016 FY	9.49 Billion INR	0.73%
2016 Q4	9.49 Billion INR	0.0%
2015 Q4	9.42 Billion INR	0.0%
2015 FY	9.42 Billion INR	1.08%
2015 Q2	7.74 Billion INR	0.0%
2014 Q2	7.2 Billion INR	0.0%
2014 FY	9.32 Billion INR	5.97%
2014 Q4	9.32 Billion INR	0.0%
2013 Q2	8.63 Billion INR	0.0%
2013 Q4	8.8 Billion INR	0.0%
2013 FY	8.8 Billion INR	-1.01%
2012 Q4	8.89 Billion INR	0.0%
2012 FY	8.89 Billion INR	19.24%
2011 FY	7.45 Billion INR	-14.19%
2011 Q4	7.45 Billion INR	0.0%
2010 FY	8.68 Billion INR	12.4%
2009 FY	7.73 Billion INR	7.01%
2008 FY	7.22 Billion INR	9.79%
2007 FY	6.57 Billion INR	17.3%
2006 FY	5.6 Billion INR	72.34%
2005 FY	3.25 Billion INR	0.0%

Peer Total Debt Comparison of Dishman Carbogen Amcis Limited

Name	Total Debt	Total Debt Difference
Biocon Limited	162.76 Billion INR	85.792%
Blue Jet Healthcare Limited	16.12 Million INR	-143272.607%
Concord Biotech Limited	97.37 Million INR	-23649.178%
Jubilant Ingrevia Limited	7.4 Billion INR	-212.408%
Lyka Labs Limited	586.5 Million INR	-3843.045%
Panacea Biotec Limited	209.9 Million INR	-10917.627%
Piramal Pharma Limited	47.1 Billion INR	50.902%
SMS Lifesciences India Limited	1 Billion INR	-2195.982%
Supriya Lifescience Limited	54.88 Million INR	-42039.213%
Syngene International Limited	5.55 Billion INR	-316.535%
TAKE Solutions Limited	370.85 Million INR	-6135.944%
Zota Health Care Limited	952.84 Million INR	-2327.045%